Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

13.72
BATS BZX Real-Time Price
As of 1:46pm ET
 -1.87 / -11.99%
Today’s Change
9.16
Today|||52-Week Range
17.55
-18.58%
Year-to-Date

Today’s Trading

Previous close15.59
Today’s open15.23
Day’s range13.61 - 15.24
Volume132,701
Average volume (3 months)1,587,188
Market cap$2.1B
Dividend yield--
Data as of 1:46pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-62.06%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book328.07

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...-0.96-2.18%
DBVTDBV Technologies SA-1.14-3.41%
PRAHPRA Health Sciences ...-0.24-0.54%
LXRXLexicon Pharmaceutic...-0.70-5.34%
Data as of 1:46pm ET, 05/04/2016

Financials

Last reporting dateMay 4, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs